Business

Views on running a successful MedTech company.

53 blogs about the topic

Industry dialogue
Access Business

Posted on 03.08.2011

HTA in Medical Technology – The Displacement of Concepts

I’m fascinated by organisations. In particular, I’m in intrigued by the way some organisations succeed at their chosen task whilst others fail. There are, of course, lots of explanations for what separates “the wheat from the chaff”, as we English say. Some academics say it is the firms’ capabilities and resources, others their culture, still others put it down to leadership. But all of these are what one might call “static” explanations.

By Brian Smith Adjunct Professor at SDA Bocconi

shout
Business

Posted on 18.07.2011

Hear, hear! We can really help current and future medical technology SMEs to innovate!

Small and medium sized enterprises (SMEs) are the lifeblood of the medical technology industry. Research in the medical technology industry, which typically occurs at the bedside not at the bench, is usually a result of small or micro collaborations between health professionals, academia and SMEs. This research model brings rapid innovation, which quickly tackles current and emerging medical needs. This innovation can only be good news for under-pressure European healthcare systems as there is clear evidence that more effective treatments are capable of delivering clear benefits; reduced hospital stays (with an associated reduction in cost of treatment); better outcomes, and faster rehabilitation and return to society.

By Sharon Higgins Chair, Eucomed SME Task Force

communicate
Business

Posted on 22.06.2011

Failure to communicate the MedTech value proposition threatens industry

At 95 billion Euros the European medical technology market and industry is far from insignificant. Its impact on the lives of patients combined with the ability of health systems to operate efficiently dwarfs the value of the market while the industry has spawned hundreds of early stage companies year on year. Despite its size the medical technology market is less than 5% of total health spend and that figure appears to be declining.

By John Wilkinson Former Chief Executive of Eucomed

differentiate now
Business

Posted on 30.05.2011

Changing environment for medical device companies? Differentiate now or fail later

Korn/Ferry International and Eucomed are co-organising the upcoming “How to differentiate in a changing environment?” conference taking place on 5 July 2011 in Brussels. We have worked closely together to design an exciting programme that will give participants a broad view on the future from a health economic point of view, but the various sessions will also discuss what hospitals are looking for from medical device companies. In addition, we have invited accomplished speakers representing other industries’ perspectives and experiences. In short, this meeting is designed to allow the exchange of experience and ideas, and see what is done in other industries to help medical device companies enhance their competitiveness and remain healthy businesses.

By Ulrika Hagle Managing Director Medical Devices EMEA Korn/Ferry International

bike-1882
Business Value

Posted on 14.04.2011

To the MedTech industry: don’t stick to old-fashioned business models when talking about the value of your technologies

Medicine became evidence-based a long time ago and rightfully so. So why is it that policy decisions are, still today, far from evidence-based in Europe? Why are healthcare managers and decision makers still relying upon short-term cost containment objectives when it comes to access, regulation and evaluation of new technologies?

By Rosanna Tarricone Director Master of International Health Care Management, Economics and Policy

letters-random
Business

Posted on 01.04.2011

UDI, GS1, GTIN, GHTF, ETF, EHR, ISMP… What does it mean to me and to you?

Having been involved with the medical devices industry for many years, I’ve seen how the industry has evolved using innovative solutions and has constantly embraced technological developments. Recently however I had a friend on the receiving end of this technology and I hope you find his ‘patient case report’ below of interest – do note he also works in the medtech industry hence his knowledge on this subject…

By Mike Kreuzer Chairman of the Eucomed Taskforce on E-Business and Supply Chain Management (ETF)

Fotolia_61156582_Subscription_Monthly_M
Business

Posted on 26.01.2011

On markets and double standards

Just before the Christmas break I purchased a beautiful flat screen television of exactly the same dimensions as one that I had bought four years previously. The price was something like 25% of what I had paid earlier and the picture much better. I also engaged in a renegotiation of my mobile phone contract and […]

By John Wilkinson Former Chief Executive of Eucomed

Fotolia_44858376_Subscription_Monthly_M
Business

Posted on 11.01.2011

2011 Outlook: Innovate or Fail

The turn of the year brings all manner of analysis of the events of one year and predictions for the year ahead. 2010 will not be fondly remembered by many as it heralded the impact of the 2008 banking crisis on the real world of citizens and business. For those in the public sector and […]

By John Wilkinson Former Chief Executive of Eucomed

comply
Business Regulation

Posted on 10.01.2011

Panel-mania? The future of an advisory interpretation

Eucomed published on 23 December 2010 its first Compliance Panel recommendation on the sponsorship of third party educational conferences by Eucomed members. The Panel, an independent body of three external opinion leading experts, was appointed to help provide guidance on the interpretation of the Eucomed Code of Ethical Business Practice as well as drive European harmonisation with […]

By Aline Lautenberg MedTech Europe, General Counsel - Director Legal & Compliance